| Index | — | P/E | 7.08 | EPS (ttm) | 4.75 | Insider Own | 16.40% | Shs Outstand | 93.00M | Perf Week | -3.56% |
| Market Cap | 3.13B | Forward P/E | 11.54 | EPS next Y | 2.91 | Insider Trans | -1.10% | Shs Float | 90.36M | Perf Month | 11.51% |
| Enterprise Value | 2.76B | PEG | 0.75 | EPS next Q | 0.58 | Short Float | 16.63% | Perf Quarter | -2.27% | ||
| Income | 458.00M | P/S | 1.85 | EPS this Y | 12.63% | Short Ratio | 6.57 | Perf Half Y | 14.63% | ||
| Sales | 1.69B | P/B | 5.27 | EPS next Y | 7.56% | ROA | 27.62% | Short Interest | 15.03M | Perf YTD | 10.41% |
| Book/sh | 6.38 | P/C | 7.55 | EPS next 5Y | 9.38% | ROE | 114.57% | 52W High | 41.78 -19.55% | Perf Year | 60.89% |
| Cash/sh | 4.45 | P/FCF | 4.20 | EPS past 3/5Y | 63.30% 3.08% | ROIC | 11.61% | 52W Low | 20.54 63.63% | Perf 3Y | -20.47% |
| Dividend Est. | — | EV/EBITDA | 3.92 | Sales past 3/5Y | -2.51% -1.96% | Gross Margin | 60.91% | Volatility | 3.59% 3.43% | Perf 5Y | -42.93% |
| Dividend TTM | — | EV/Sales | 1.63 | EPS Y/Y TTM | 320.35% | Oper. Margin | 7.63% | ATR (14) | 1.12 | Perf 10Y | 14.55% |
| Dividend Ex-Date | — | Quick Ratio | 0.91 | Sales Y/Y TTM | 0.96% | Profit Margin | 27.08% | RSI (14) | 61.28 | Recom | 2.89 |
| Dividend Gr. 3/5Y | — | Current Ratio | 0.91 | EPS Q/Q | 46.81% | SMA20 | 4.24% | Beta | 0.57 | Target Price | 31.33 |
| Payout | 0.00% | Debt/Eq | 0.09 | Sales Q/Q | 0.49% | SMA50 | 11.57% | Rel Volume | 1.04 | Prev Close | 34.25 |
| Employees | 5,100 | LT Debt/Eq | 0.09 | Earnings | Nov 05 | SMA200 | 12.32% | Avg Volume | 2.01M | Price | 33.61 |
| IPO Date | Oct 01, 2007 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 23.75% 3.50% | Net Debt/EBITDA | -0.51 | Volume | 2,096,158 | Change | -1.87% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Sep-21-26 | Reiterated | UBS | Neutral | $34 → $32 |
| Aug-10-26 | Downgrade | Morgan Stanley | Overweight → Equal Weight | |
| Jul-16-26 | Reiterated | RBC Capital | Sector Perform | $29 → $34 |
| May-06-26 | Reiterated | UBS | Neutral | $36 → $34 |
| May-06-26 | Reiterated | Barclays | Underweight | $27 → $28 |
| Feb-11-26 | Reiterated | Northland Securities | Outperform | $24 → $37 |
| Feb-11-26 | Reiterated | UBS | Neutral | $23 → $36 |
| Feb-11-26 | Reiterated | Evercore ISI Group | Outperform | $37 → $40 |
| Jan-12-26 | Reiterated | Barclays | Underweight | $24 → $27 |
| Dec-17-25 | Reiterated | Morgan Stanley | Overweight | $29 → $35 |
Teradata Corporation, through its various entities, delivers a unified multi-cloud data platform specifically engineered for robust enterprise analytics. A cornerstone of its product suite is Teradata Vantage, a cutting-edge data platform designed to enable businesses to harness their data comprehensively across the entire organization. This platform excels at integrating diverse data sources, thereby simplifying intricate data ecosystems and assisting customers with their migration to cloud environments through an integrated approach. Beyond its core platform, Teradata offers specialized business consulting, which aids organizations in formulating a precise data and analytics vision, uncovering and putting into practice analytical opportunities, architecting effective multi-cloud environments, and ensuring their analytical infrastructure generates measurable value. The company further augments its offerings with essential support and maintenance services. Serving a broad spectrum of industries such as financial services, government, healthcare, manufacturing, retail, telecommunications, and travel/transportation, Teradata engages its global customer base through a direct sales network spanning the Americas, Europe, the Middle East, Africa, the Asia Pacific region, and Japan. Teradata Corporation, founded in 1979, maintains its principal offices in San Diego, California.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,691 | 1,663 | 1,750 | 1,833 | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 661 | 670 | 692 | 718 | — | — | — | — | — | |
| Gross Profit | 1,030 | 993 | 1,058 | 1,115 | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 611 | 481 | 565 | 635 | — | — | — | — | — | |
| Research and Development | 290 | 280 | 284 | 294 | — | — | — | — | — | |
| Other Operating Expense | 0 | 27 | 0 | 0 | — | — | — | — | — | |
| Operating Income | 129 | 205 | 209 | 186 | — | — | — | — | — | |
| Interest Expense | 25 | 26 | 29 | 30 | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 487 | -1 | -16 | -39 | — | — | — | — | — | |
| Net Income Before Taxes | 591 | 178 | 164 | 117 | — | — | — | — | — | |
| Income Taxes | 133 | 48 | 50 | 55 | — | — | — | — | — | |
| Consolidated Net Income | 458 | 130 | 114 | 62 | — | — | — | — | — | |
| Net Income From Continuing Operations | 458 | 130 | 114 | 62 | — | — | — | — | — | |
| Net Income | 458 | 130 | 114 | 62 | — | — | — | — | — | |
| EPS (Recurring) | 4.91 | 1.38 | 1.18 | 0.62 | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 4.91 | 1.38 | 1.18 | 0.62 | — | — | — | — | — | |
| EPS (Diluted) | 4.75 | 1.35 | 1.16 | 0.61 | — | — | — | — | — | |
| EBITDA | 705 | 268 | 293 | 263 | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 7.08 | 22.55 | 26.85 | 71.33 | — | — | — | — | — | |
| Price To Sales Ratio | 1.87 | 1.72 | 1.71 | 2.37 | — | — | — | — | — | |
| Gross Margin | 60.91 | 59.71 | 60.46 | 60.83 | — | — | — | — | — | |
| Operating Margin | 7.63 | 12.33 | 11.94 | 10.15 | — | — | — | — | — | |
| Net Margin | 27.08 | 7.82 | 6.51 | 3.38 | — | — | — | — | — | |
| Shares Outstanding | 94 | 94 | 96 | 100 | — | — | — | — | — | |
| Market Capitalization | 3,159 | 2,861 | 2,990 | 4,351 | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| MCMILLAN STEPHEN | President and CEO | Sep 15 '26 | Sale | 30.02 | 10,000 | 300,170 | 752,446 | Sep 17 |
| Hutchinson Michael D | Chief Operating Officer | Sep 15 '26 | Sale | 30.00 | 48,077 | 1,442,310 | 171,927 | Sep 17 |
| CHOU TIMOTHY C K | Director | Jun 08 '26 | Sale | 33.72 | 5,657 | 190,754 | 39,210 | Jun 10 |
| Petley Richard J | Chief Revenue Officer | Jun 01 '26 | Sale | 35.00 | 17,227 | 602,952 | 188,571 | Jun 02 |
| McElhatton Todd | Director | May 22 '26 | Sale | 33.47 | 15,000 | 502,022 | 26,665 | May 26 |
| Arora Sumeet | Chief Product Officer | May 19 '26 | Sale | 33.00 | 15,000 | 495,000 | 250,772 | May 20 |
| MCMILLAN STEPHEN | President and CEO | May 12 '26 | Sale | 31.71 | 20,000 | 634,158 | 762,446 | May 13 |
| Arora Sumeet | Chief Product Officer | May 07 '26 | Sale | 30.84 | 2,645 | 81,572 | 301,452 | May 08 |
| Petley Richard J | Chief Revenue Officer | May 07 '26 | Sale | 30.84 | 34,317 | 1,058,336 | 207,627 | May 08 |
| MCMILLAN STEPHEN | President and CEO | Feb 26 '26 | Sale | 30.26 | 50,000 | 1,513,125 | 663,190 | Feb 27 |
| Gianoni Michael P | Director | Feb 24 '26 | Sale | 29.96 | 25,000 | 749,125 | 31,523 | Feb 25 |
| Lynrock Lake LP | 10% Owner | Feb 11 '26 | Sale | 40.29 | 61,990 | 2,497,507 | 9,354,676 | Feb 13 |
| CHOU TIMOTHY C K | Director | May 22 '25 | Sale | 21.83 | 6,216 | 135,695 | 36,077 | May 27 |
| BRAMLEY CLAIRE | Chief Financial Officer | Mar 10 '25 | Sale | 22.83 | 35,464 | 809,646 | 105,833 | Mar 11 |
| Cullen-Cote Kathleen R | Chief People Officer | Mar 07 '25 | Sale | 22.88 | 1,755 | 40,154 | 142,707 | Mar 10 |